Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Peer Christiansen"'
Autor:
Per Damkier, Timothy L. Lash, Thomas P. Ahern, Henrik Toft Sørensen, Deirdre Cronin-Fenton, Bent Ejlertsen, Peer Christiansen
Publikováno v:
Cronin-Fenton, D, Lash, T L, Ahern, T P, Damkier, P, Christiansen, P, Ejlertsen, B & Sørensen, H T 2018, ' Concurrent new drug prescriptions and prognosis of early breast cancer : studies using the Danish Breast Cancer Group clinical database ', Acta Oncologica, vol. 57, no. 1, pp. 1-9 . https://doi.org/10.1080/0284186X.2017.1407040
BACKGROUND: Myriad reports suggest that frequently used prescription drugs alter the viability of breast cancer cells in pre-clinical studies. Routine use of these drugs, therefore, may impact breast cancer prognosis, and could have important implica
Autor:
Maj-Britt Jensen, Peer Christiansen, Niels Kroman, Anne Bodilsen, Bent Ejlertsen, Stina Lyck Carstensen, Birgitte Vrou Offersen
Publikováno v:
Christiansen, P, Carstensen, S L, Ejlertsen, B, Kroman, N, Offersen, B, Bodilsen, A & Jensen, M-B 2018, ' Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 57, no. 1, pp. 19-25 . https://doi.org/10.1080/0284186X.2017.1403042
BACKGROUND:Observational studies have pointed at a better survival after breast conserving surgery (BCS) compared with mastectomy. The aim of the present study was to evaluate whether this remains true when more extensive tumor characteristics and tr
Autor:
Stephen Hamilton-Dutoit, Anders Kjærsgaard, Peer Christiansen, Marianne Ewertz, Rebecca A. Silliman, Henrik Toft Sørensen, Marco Mele, Deirdre Cronin-Fenton, Timothy L. Lash, Bent Ejlertsen, Thomas P. Ahern
Publikováno v:
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 59, no. 6, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
BACKGROUND: Validation studies of the Danish Breast Cancer Group (DBCG) registry show good agreement with medical records for adjuvant treatment data, but inconsistent recurrence information. No studies have validated changes in menopausal status or
Publikováno v:
Jensen, M-B, Ejlertsen, B, Mouridsen, H T, Christiansen, P & Danish Breast Cancer Cooperative Group 2016, ' Improvements in breast cancer survival between 1995 and 2012 in Denmark : The importance of earlier diagnosis and adjuvant treatment ', Acta Oncologica, pp. 1-12 . https://doi.org/10.3109/0284186X.2015.1128119
Background Breast cancer mortality has declined from 1995 through 2012 which may be attributed to earlier diagnosis, changes in lifestyle risk factors, and improved treatments. To a large extent the relative contribution of these modalities are unkno
Autor:
Peer Christiansen, Niels Kroman, Eva Balslev, Tove Filtenborg Tvedskov, Ilse Vejborg, Maj-Britt Jensen, Bent Ejlertsen, Jens Peter Garne
Publikováno v:
Tvedskov, T F, Jensen, M-B, Balslev, E, Garne, J P, Vejborg, I, Christiansen, P, Ejlertsen, B & Kroman, N 2015, ' Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers ', Acta Oncologica, pp. 1-5 . https://doi.org/10.3109/0284186X.2015.1094186
BACKGROUND: Symptomatic breast cancers may be more aggressive as compared to screen-detected breast cancers. This could favor axillary lymph node dissection (ALND) in patients with symptomatic breast cancer and positive sentinel nodes.METHOD: We iden
Publikováno v:
Lyngholm, C D, Christiansen, P M, Damsgaard, T E & Overgaard, J 2013, ' Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 52, no. 2, pp. 259-69 . https://doi.org/10.3109/0284186X.2012.744469
The Danish Breast Cancer Cooperative Group (DBCG) introduced BCT as a standard treatment in Denmark in 1990. The aim of this study was to investigate late morbidity, cosmetic outcome, and body image after BCT and to associate these outcome variables
Publikováno v:
Lauridsen, MC, Christiansen, P M C & Hessov, I 2005, ' The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer; a randomized study ', Acta. Oncol., vol. 44, pp. 449-57 .
Lauridsen, M C, Christiansen, P & Hessov, I 2005, ' The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer : a randomized study ', Acta Oncologica, vol. 44, no. 5, pp. 449-57 . https://doi.org/10.1080/02841860510029905
Lauridsen, M C, Christiansen, P & Hessov, I 2005, ' The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer : a randomized study ', Acta Oncologica, vol. 44, no. 5, pp. 449-57 . https://doi.org/10.1080/02841860510029905
The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer was examined through a randomized controlled trial. One hundred and thirty-nine patients with newly diagnosed breast cancer were enrolled in the study.